Regulatory Decisions in a Globalised World
Rapid drug regulatory decisions regarding phenylpropanolamine (PPA)-containing common cold remedies and diet pills were taken in some Latin American countries following a Food and Drug Administration (FDA) decision in the US. This situation is described as one that illustrates the important changes that regulatory decisions are experiencing as a consequence of globalisation.
The evidence for the efficacy of PPA as a nasal decongestant and as an appetite-suppressant is very limited, at least by modern standards. Its potential to increase blood pressure and induce haemorrhagic stroke was described soon after its marketing. Although this poor benefit/risk ratio had been known for more than 20 years, regulatory action was taken in Latin America only after the US FDA withdrew the drug in the US on the basis of the results of a case-control study which added limited new evidence to the already known risk of stroke, but which, on the other hand, had attracted much attention from the media.
- 1.Stolley PD, Laporte JR. The public health, the university, and pharmacoepidemiology. In: Strom BL, editor. Pharmacoepidemiology. New York; John Wiley & Sons Ltd, 2000Google Scholar
- 2.Glaxo withdraws grepafloxacin worldwide. Scrip 1999; 2485: 21Google Scholar
- 3.Tolcapone and fatal liver injury.WHO Drug Information 1999; 13: 17Google Scholar
- 4.Rawlins, MD. Adverse reactions to drugs. BMJ 1981; 282: 974–6Google Scholar
- 5.‘E-drug’ discussion list [online]. Available from URL: http://www.healthnet.org/programs/edrug.html [Accessed 2002 Jul 16]Google Scholar
- 6.‘E-farmacos’ discussion list [online]. Available from URL: http://www.healthnet.org/programs/efarmacos.html [Accessed 2002 Jul 16]Google Scholar
- 8.Accidents cardiaques et neurologiques dûs à la phénylpropanolamine [in French]. La Revue Prescrire 1999; 19: 599Google Scholar
- 11.Phenylpropanolamine: strengthening of patient information. United Kingdom. WHO Drug Information 2001; 14: 226Google Scholar
- 12.Phenylpropanolamine and other OTC alpha-adrenergic agonists. Med Letter Drugs Ther 2000; 42: 113Google Scholar
- 13.Lee KY, Beilin LJ, Vandongen R. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin [letter]. Lancet 1979; I: 110–1Google Scholar
- 18.Taverner D, Bickford L, Draper M. Nasal decongestants for the common cold (Cochrane Review). In: The Cochrane Library, Issue 4, 2000. Oxford: Update SoftwareGoogle Scholar